Insights on habit tracking as a clinical tool for engagement, retention, and compliance.
Latest Quitting cannabis is harder than most people expect, not because it's physically brutal, but because it's quiet about it. Here's what actually helps.
Read article
Trump's April 2026 executive order on psilocybin, MDMA, ibogaine, and LSD marks a quiet turning point for harm reduction in the US. But not every substance, and not every user, made it into the frame. Here's what clinicians need to understand.
Read article
Clinicians who rely on memory and in-session self-report are flying blind between appointments. Here's what the evidence says about MBC in addiction treatment, and how to actually implement it.
Read article
Asking involuntary clients to 'just track' (without any pressure to change) is one of the most underused retention strategies in outpatient treatment. Here's why it works.
Why giving clients full control over their substance use data isn't just legally required under HIPAA and Part 2, it's clinically superior.
When a client rolls cannabis with tobacco, you're not treating one addiction. You're treating two. Most treatment plans only address one of them.
Almost every cannabis client will tell you they need it to sleep. They're not wrong, and that's exactly the problem. A clinical breakdown of the sleep-cannabis dependency loop.
Cannabis withdrawal is a recognized DSM-5 diagnosis with a predictable timeline. Here's what to expect week by week, and how to use that knowledge in treatment.
Most clients will tell you they're casual users. The DSM-5 disagrees with at least some of them. Here's how to apply the criteria in a real clinical conversation.
A deep dive into cannabis flower (bud), the difference between Indica and Sativa, and how different terpenes affect the client's experience.
Understand the connection between hash color, trichomes, and the chemical profile, and why dark hash often means a heavy, sedative experience for clients.